Correlation Between Pliant Therapeutics and Cara Therapeutic
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Cara Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Cara Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Cara Therapeutic, you can compare the effects of market volatilities on Pliant Therapeutics and Cara Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Cara Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Cara Therapeutic.
Diversification Opportunities for Pliant Therapeutics and Cara Therapeutic
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pliant and Cara is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Cara Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cara Therapeutic and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Cara Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cara Therapeutic has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Cara Therapeutic go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Cara Therapeutic
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Cara Therapeutic. But the stock apears to be less risky and, when comparing its historical volatility, Pliant Therapeutics is 1.21 times less risky than Cara Therapeutic. The stock trades about -0.03 of its potential returns per unit of risk. The Cara Therapeutic is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 475.00 in Cara Therapeutic on November 9, 2024 and sell it today you would earn a total of 37.00 from holding Cara Therapeutic or generate 7.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Cara Therapeutic
Performance |
| Timeline |
| Pliant Therapeutics |
| Cara Therapeutic |
Pliant Therapeutics and Cara Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Cara Therapeutic
The main advantage of trading using opposite Pliant Therapeutics and Cara Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Cara Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cara Therapeutic will offset losses from the drop in Cara Therapeutic's long position.| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
| Cara Therapeutic vs. 22nd Century Group | Cara Therapeutic vs. Corbus Pharmaceuticals Holding | Cara Therapeutic vs. Cannabis Sativa | Cara Therapeutic vs. General Cannabis Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |